Updates to the Drug Benefit List - Fall 2005
Additions - All Provinces
Except Quebec
Additions - Quebec Only
Delisted Benefits
Drugs Discontinued
Replacement DINs
Change in Status
Name Change
Limited Use Benefits
Additions to the Drug Benefit List - All Provinces Except Quebec
This Fall update identifies changes made to the Non-Insured Health
Benefits (NIHB) Drug Benefit List (DBL) since the Summer 2005 update.
The recent changes announced in this Fall 2005 update are reflected
in the electronic version of the NIHB DBL dated October 2005. Please
refer to the Web site at the following URL address:
http://www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html_drug-med-list
Effective Date: 2005-06-01
| DIN |
MFR |
BRAND NAME |
PTC |
| 02266350 |
NOP |
NOVO-CILAZAPRIL 1MG TABLET |
24:32.04 |
| 02266369 |
NOP |
NOVO-CILAZAPRIL 2.5MG TABLET |
24:32.04 |
| 02266377 |
NOP |
NOVO-CILAZAPRIL 5MG TABLET |
24:32.04 |
Effective Date: 2005-07-01
| DIN |
MFR |
BRAND NAME |
PTC |
| 02247809 |
TIP
|
ALCOHOL 70% SWABS
|
94:01.00 |
| 02266008 |
APX |
APO-FOSINOPRIL 10MG TABLET |
24:32.04 |
| 02266016 |
APX |
APO-FOSINOPRIL 20MG TABLET |
24:32.04 |
| 02266695 |
APX |
APO-LITHIUM CARBONATE SR
300MG EXTENDED RELEASE TABLET |
28:28.00 |
| 02257637 |
BAK |
BCI-ATENOLOL 100MG TABLET |
24:24.00 |
| 02265575 |
BAK |
BCI-METFORMIN 500MG TABLET |
68:20.04 |
| 02265583 |
BAK |
BCI-METFORMIN 850MG TABLET |
68:20.04 |
| 02265613 |
BAK |
BCI-PRAVASTATIN 10MG TABLET |
24:06.08 |
| 02265621 |
BAK |
BCI-PRAVASTATIN 20MG TABLET |
24:06.08 |
| 02265648 |
BAK |
BCI-PRAVASTATIN 40MG TABLET |
24:06.08 |
| 02265591 |
BAK |
BCI-RANITIDINE 150MG TABLET |
56:28.12 |
| 02265605 |
BAK |
BCI-RANITIDINE 300MG TABLET |
56:28.12 |
| 02265656 |
BAK |
BCI-SIMVASTATIN 5MG TABLET |
24:06.08 |
| 02265664 |
BAK |
BCI-SIMVASTATIN 10MG TABLET |
24:06.08 |
| 02265672 |
BAK |
BCI-SIMVASTATIN 20MG TABLET |
24:06.08 |
| 02265680 |
BAK |
BCI-SIMVASTATIN 40MG TABLET |
24:06.08 |
| 02265699 |
BAK |
BCI-SIMVASTATIN 80MG TABLET |
24:06.08 |
| 02242261 |
EUR |
EURO-K 20 20MMOL LONG ACTING
TABLET |
40:12.00 |
| 02265494 |
GEN |
GEN-LAMOTRIGINE 25MG TABLET |
28:12.92 |
| 02265508 |
GEN |
GEN-LAMOTRIGINE 100MG TABLET |
28:12.92 |
| 02265516 |
GEN |
GEN-LAMOTRIGINE 150MG TABLET |
28:12.92 |
00713376
|
KEY
|
K-DUR 1500MG EXTENDED-RELEASE
TABLET |
40:12.00 |
| 02260662 |
PHH |
PHL-VALPROIC ACID E.C. 500MG
CAPSULE |
28:12.92 |
| 02255944 |
PMS |
PMS-FOSINOPRIL 10MG TABLET |
24:32.04 |
| 02255952 |
PMS |
PMS-FOSINOPRIL 20MG TABLET |
24:32.04 |
| 02260883 |
RPH |
RATIO-GABAPENTIN 100MG CAPSULE |
28:12.92 |
| 02260891 |
RPH |
RATIO-GABAPENTIN 300MG CAPSULE |
28:12.92 |
| 02260905 |
RPH |
RATIO-GABAPENTIN 400MG CAPSULE |
28:12.92 |
| 02243975 |
RIV |
RIVA-K20 20MMOL EXTENDED-RELEASE
TABLET |
40:12.00 |
Effective Date: 2005-08-01
| DIN |
MFR |
BRAND NAME |
PTC |
02257629
|
BAK
|
BCI-ATENOLOL 50MG TABLET
|
24:24.00 |
| 02237450 |
EUR |
D-FORTE 50,000IU CAPSULE |
88:16.00 |
| 02250675 |
EUR |
EURO-ASA 80MG TABLET |
28:08.04 |
| 02237351 |
EUR |
EURO-CAL D 500MG TABLET |
88:28.00 |
| 02246733 |
EUR |
EURO-FERROUS SULFATE 300MG
TABLET |
20:04.04 |
| 02246734 |
EUR |
EURO-K 600 8MMOL LONG ACTING
TABLET |
40:12.00 |
| 02247383 |
EUR |
EURO-LAC 667MG/ML SYRUP |
40:10.00 |
| 02247389 |
EUR |
EURO-SENNA 8.6MG TABLET |
56:12.00 |
| 02242863 |
EUR |
PEDIAFER 6MG/ML SYRUP |
20:04.04 |
Effective Date: 2005-09-01
| DIN |
MFR |
BRAND NAME |
PTC |
02248239
|
SAW
|
ELIGARD 7.5MG/VIAL INJECTION
|
10:00.00 |
| 02248240 |
SAW |
ELIGARD 22.5MG/VIAL INJECTION |
10:00.00 |
| 02248999 |
SAW |
ELIGARD 30MG/VIAL INJECTION |
10:00.00 |
| 02253631 |
SPH |
TEVETEN PLUS 600MG & 12.5MG
TABLET |
24:32.08 |
Additions to the Drug Benefit List - Quebec Only
This Fall update identifies changes made to the NIHB Drug Benefit
List (DBL) since the Summer 2005 update.
The recent changes announced in this Fall 2005 update are reflected
in the electronic version of the NIHB DBL dated October 2005. Please
refer to the Web site at the following URL address:
http://www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html_drug-med-list
Effective Date: 2005-06-01
| DIN |
MFR |
BRAND NAME |
PTC |
| 02266350 |
NOP
|
NOVO-CILAZAPRIL 1MG TABLET
|
24:32.04 |
| 02266369 |
NOP |
NOVO-CILAZAPRIL 2.5MG TABLET |
24:32.04 |
| 02266377 |
NOP |
NOVO-CILAZAPRIL 5MG TABLET |
24:32.04 |
Effective Date: 2005-07-01
| DIN |
MFR |
BRAND NAME |
PTC |
02247809
|
TIP
|
ALCOHOL 70% SWABS
|
94:01.00 |
| 02266008 |
APX |
APO-FOSINOPRIL 10MG TABLET |
24:32.04 |
| 02266016 |
APX |
APO-FOSINOPRIL 20MG TABLETT |
24:32.04 |
02266695
|
APX
|
APO-LITHIUM CARBONATE SR
300MG EXTENDED RELEASE TABLET
|
28:28.00 |
| 02257637 |
BAK |
BCI-ATENOLOL 100MG TABLET |
24:24.00 |
| 02265575 |
BAK |
BCI-METFORMIN 500MG TABLET |
68:20.04 |
| 02265583 |
BAK |
BCI-METFORMIN 850MG TABLET |
68:20.04 |
02265613
|
BAK
|
BCI-PRAVASTATIN 10MG TABLET
|
24:06.08 |
| 02265621 |
BAK |
BCI-PRAVASTATIN 20MG TABLET |
24:06.08 |
| 02265648 |
BAK |
BCI-PRAVASTATIN 40MG TABLET |
24:06.08 |
02265591
|
BAK
|
BCI-RANITIDINE 150MG TABLET
|
56:28.12 |
| 02265605 |
BAK |
BCI-RANITIDINE 300MG TABLET |
56:28.12 |
| 02265656 |
BAK |
BCI-SIMVASTATIN 5MG TABLET |
24:06.08 |
| 02265664 |
BAK |
BCI-SIMVASTATIN 10MG TABLET |
24:06.08 |
| 02265672 |
BAK |
BCI-SIMVASTATIN 20MG TABLET |
24:06.08 |
02265680
|
BAK
|
BCI-SIMVASTATIN 40MG TABLET
|
24:06.08 |
| 02265699 |
BAK |
BCI-SIMVASTATIN 80MG TABLET |
24:06.08 |
| 02242261 |
EUR |
EURO-K 20 20MMOL LONG ACTING
TABLET |
40:12.00 |
02265494
|
GEN
|
GEN-LAMOTRIGINE 25MG TABLET
|
28:12.92 |
| 02265508 |
GEN |
GEN-LAMOTRIGINE 100MG TABLET |
28:12.92 |
| 02265516 |
GEN |
GEN-LAMOTRIGINE 150MG TABLET |
28:12.92 |
| 00713376 |
KEY
|
K-DUR 1500MG EXTENDED-RELEASE
TABLET |
40:12.00 |
| 02260662 |
PHH |
PHL-VALPROIC ACID E.C. 500MG
CAPSULE |
28:12.92 |
02255944
|
PMS
|
PMS-FOSINOPRIL 10MG TABLET
|
24:32.04 |
| 02255952 |
PMS |
PMS-FOSINOPRIL 20MG TABLET |
24:32.04 |
| 02260883 |
RPH |
RATIO-GABAPENTIN 100MG CAPSULE |
28:12.92 |
02260891
|
RPH
|
RATIO-GABAPENTIN 300MG CAPSULE
|
28:12.92 |
| 02260905 |
RPH |
RATIO-GABAPENTIN 400MG CAPSULE |
28:12.92 |
| 02243975 |
RIV |
RIVA-K20 20MMOL EXTENDED-RELEASE
TABLET |
40:12.00 |
Effective 2005-08-01
| DIN |
MFR |
BRAND NAME |
PTC |
02257629
|
BAK
|
BCI-ATENOLOL 50MG TABLET
|
24:24.00 |
| 02237450 |
EUR |
D-FORTE 50,000IU CAPSULE |
88:16.00 |
| 02250675 |
EUR |
EURO-ASA 80MG TABLET |
28:08.04 |
02237351
|
EUR
|
EURO-CAL D 500MG TABLET
|
88:28.00 |
| 02246733 |
EUR |
EURO-FERROUS SULFATE 300MG
TABLET |
20:04.04 |
| 02246734 |
EUR |
EURO-K 600 8MMOL LONG ACTING
TABLET |
40:12.00 |
| 02247383 |
EUR |
EURO-LAC 667MG/ML SYRUP |
40:10.00 |
02247389
|
EUR
|
EURO-SENNA 8.6MG TABLET
|
56:12.00 |
| 02242863 |
EUR |
PEDIAFER 6MG/ML SYRUP |
20:04.04 |
Effective: 2005-09-01
| DIN |
MFR |
BRAND NAME |
PTC |
02248239
|
SAW
|
ELIGARD 7.5MG/VIAL INJECTION
|
10:00.00 |
| 02248240 |
SAW |
ELIGARD 22.5MG/VIAL INJECTION |
10:00.00 |
| 02248999 |
SAW |
ELIGARD 30MG/VIAL INJECTION |
10:00.00 |
| 02253631 |
SPH |
TEVETEN PLUS 600MG & 12.5MG
TABLET |
24:32.08 |
Delisted Benefits
There are no delisted items for the Fall 2005 update.
Drugs Discontinued
This Fall update identifies changes made to the NIHB Drug Benefit
List (DBL) since the Summer 2005 update.
The recent changes announced in this Fall 2005 update are reflected
in the electronic version of the NIHB DBL dated October 2005.
Please refer to the Web site at the following URL address:
http://www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html_drug-med-list
| DIN |
MFR |
BRAND NAME |
PTC |
02248182
|
COB
|
CO-PRAVASTATIN 10MG TABLET
|
24:06.08 |
| 02248183 |
COB |
CO-PRAVASTATIN 20MG TABLET |
24:06.08 |
| 02248184 |
COB |
CO-PRAVASTATIN 40MG TABLET |
24:06.08 |
| 02241478 |
EUR |
PEDIAPHEN 80MG TABLET |
28:08.92 |
| 02241479 |
EUR |
PEDIAPHEN 160MG TABLET |
28:08.92 |
| 00775320 |
PMS |
PMS-THIORIDZAINE 30MG/ML
SOLUTION |
28:16.08 |
| 00028053 |
SCH |
SODIUM SULAMYD 10% OPHTH
SOLUTION |
52:04.04 |
Replacement DINs
There are no replacement DINs for the Fall 2005 update.
Change in Status
This Fall update identifies changes made to the NIHB Drug Benefit
List (DBL) since the Summer 2005 update.
The recent changes announced in this Fall 2005 update are reflected
in the electronic version of the NIHB DBL dated October 2005. Please
refer to the Web site at the following URL address:
http://www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html_drug-med-list
Effective Date: 2005-10-01
The status of Fentanyl (Duragesic) will change from an Open Benefit
to a Limited Use Benefit for the management of chronic pain in
patients who are unresponsive or intolerant to at least one long-acting
oral sustained released product, such as morphine, hydromorphone
and oxycodone, despite appropriate dose titration and adjunctive
therapy including laxatives and antiemetics. The affected DINs
are:
| DIN |
MFR |
BRAND NAME |
PTC |
01937383
|
JNO
|
DURAGESIC 25MCG/H PATCH
|
28:08.08 |
| 01937391 |
JNO |
DURAGESIC 50MCG/H PATCH |
28:08.08 |
| 01937405 |
JNO |
DURAGESIC 75MCG/H PATCH |
28:08.08 |
| 01937413 |
JNO |
DURAGESIC 100MCG/H PATCH |
28:08.08 |
Effective Date: 2005-10-01
The status of Cyclosporine (Neoral) will change from an Open Benefit
to a Limited Use Benefit for transplant therapy. The affected DINs
are:
| DIN |
MFR |
BRAND NAME |
PTC |
02244324
|
APX
|
APO-CYCLOSPORINE 100MG/ML
SOLUTION
|
92:00.00 |
| 02150697 |
NVR |
NEORAL 100MG/ML SOLUTION |
92:00.00 |
| 02237671 |
NVR |
NEORAL 10MG CAPSULE |
92:00.00 |
| 02150689 |
NVR |
NEORAL 25MG CAPSULE |
92:00.00 |
| 02150662 |
NVR |
NEORAL 50MG CAPSULE |
92:00.00 |
| 02150670 |
NVR |
NEORAL 100MG CAPSULE |
92:00.00 |
| 02242821 |
RHO |
RHOXAL-CYCLOSPORINE 100MG
CAPSULE |
92:00.00 |
Effective Date: 2005-10-01
The status of Mycophenolate (Cellcept) will change from an Open
Benefit to a Limited Use Benefit for transplant therapy. The affected
DINs are:
| DIN |
MFR |
BRAND NAME |
PTC |
02192748
|
HLR
|
CELLCEPT 250MG CAPSULE
|
92:00.00 |
| 02237484 |
HLR |
CELLCEPT 500MG TABLET |
92:00.00 |
Effective Date: 2005-10-01
The status of Tacrolimus (Prograf) will change from an Open Benefit
to a Limited Use Benefit for transplant therapy. The affected DINs
are
| DIN |
MFR |
BRAND NAME |
PTC |
02243144
|
AST
|
PROGRAF 0.5MG CAPSULE
|
92:00.00 |
| 02175991 |
AST |
PROGRAF 1MG CAPSULE |
92:00.00 |
| 02175983 |
AST |
PROGRAF 5MG CAPSULE |
92:00.00 |
| 02176009 |
AST |
PROGRAF 5MG/ML INJECTION |
92:00.00 |
Name Change
This Fall update identifies changes made to the NIHB Drug Benefit
List (DBL) since the Summer 2005 update.
The recent changes announced in this Fall 2005 update are reflected
in the electronic version of the NIHB DBL dated October 2005. Please
refer to the Web site at the following URL address:
http://www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html_drug-med-list
| DIN |
MFR |
OLD BRAND NAME |
NEW BRAND NAME |
PTC |
02232202
|
EUR
|
FEROVIT 15MG/ML DROP
|
PEDIAFER 15MG/ML DROP
|
20:04.04 |
| 02229790 |
EUR |
TRI-O-VIT 2,500IU & 666.67IU & 50MG/ML
DROP |
PEDIAVIT 2,500IU & 666.67IU &
50MG/ML DROP |
88:28.00 |
Limited Use Benefits
This Fall update identifies changes made to the NIHB Drug Benefit
List (DBL) since the Summer 2005 update. Please refer to the Web
site at the following URL address for the criteria:
http://www.hc-sc.gc.ca/fnih-spni/pubs/drug-med/benefits-criteria-restreint-criteres/index_e.html
The recent changes announced in this Fall 2005 update are reflected
in the electronic version of the NIHB DBL dated October 2005. Please
refer to the Web site at the following URL address:
http://www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html_drug-med-list
Effective Date: 2005-07-01
| DIN |
MFR |
BRAND NAME |
PTC |
02248730
|
APX
|
APO-ALENDRONATE 70MG TABLET
|
92:00.00 |
| 02261715 |
NOP |
NOVO-ALENDRONATE 70MG TABLET |
92:00.00 |
Effective Date: 2005-08-01
| DIN |
MFR |
BRAND NAME |
PTC |
02258102
|
COB
|
CO-ALENDRONATE 40MG TABLET
|
92:00.00 |
| 02258110 |
COB |
CO-ALENDRONATE 70MG TABLET |
92:00.00 |
Effective Date: 2005-10-01
| DIN |
MFR |
BRAND NAME |
PTC |
02248297
|
JNO
|
EVRA 6.0MG/0.60MG TRANSDERMAL PATCH
|
68:12.00 |
| 02258595 |
ABB |
HUMIRA 40MG/VIAL INJECTION |
92:00.00 |
|
